Roche’s acquisition of Kapa Biosystems for USD 445 million

Lead party: Roche (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Kapa Biosystems, Inc. Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions, Venture Capital · Strategy: Acquisition, Venture Equity · Instrument: Equity · Deal amount: US$445m Lead investor/buyer: Roche · Investors/buyers: Roche Legal advisers: not identified in…


Lead party: Roche (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Kapa Biosystems, Inc.

Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions, Venture Capital · Strategy: Acquisition, Venture Equity · Instrument: Equity · Deal amount: US$445m

Lead investor/buyer: Roche · Investors/buyers: Roche

Legal advisers: not identified in the source record.

Source: announced 19 August 2015. Original announcement: prnewswire.com.